RECENT PROGRESS IN ALLERGEN IMMUNOTHERAPY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NOURI ARIA K.T.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Immunology Year:2008 | Volume:5 | Issue:1 Page(s): 1-24

Download Full-Text

View:

478

Download:

197

Cites:

Information Journal Paper

Title

RECENT PROGRESS IN ALLERGEN IMMUNOTHERAPY

Author(s)

NOURI ARIA K.T. | Issue Writer Certificate

Keywords

ALLERGY

IGE

RHINITIS

IMMUNOTHERAPY

Abstract

The efficacy of allergen IMMUNOTHERAPY for the treatment of allergic rhinoconjunctivitis with or without seasonal bronchial asthma and anaphylaxis caused by the sting of the hymenoptera class of insects has been clearly demonstrated in numerous well-designed, placebo-controlled trials. IMMUNOTHERAPY whether by subcutaneous injection of allergen extract or by oral/sublingual routes modifies peripheral and mucosal TH2 responses in favour of TH1 responses and augments IL-10 synthesis by TRegs both locally and by peripheral T cells. Recent researches into the cellular and molecular basis of allergic reactions have advanced our understanding of the mechanisms involved in allergic diseases. They have also helped the development of innovative approaches that are likely to further improve the control of allergic responses in the future. Novel approaches to IMMUNOTHERAPY that are currently being explored include the use of peptide-based allergen preparations, which do not bind IGE and therefore do not activate mast cells, but reduce both TH1 and TH2-cytokine synthesis, while increasing levels of IL-10. Alternative strategies include the use of adjuvants, such as nucleotide immunostimulatory sequences derived from bacteria CpG or monophosphoryl lipid A that potentiate TH1 responses. Blocking the effects of IGE using anti-IgE such as omalizumab, a recombinant humanized monoclonal antibody that selectively binds to IGE, has been shown to be a useful strategy in the treatment of allergic asthma and RHINITIS. The combination of anti-IgE-monoclonal antibody omalizumab with allergen IMMUNOTHERAPY has proved beneficial for the treatment of allergic diseases, offering improved efficacy, limited adverse effects, and potential immune-modifying effects. This combination may also accelerate the rapidity by which IMMUNOTHERAPY induces TReg cells. If allergic diseases are due to a lack of allergen-specific TReg cells, then effective therapies should target the induction and the development of TReg cells producing cytokines such as IL-10.

Cites

No record.

References

No record.

Cite

APA: Copy

NOURI ARIA, K.T.. (2008). RECENT PROGRESS IN ALLERGEN IMMUNOTHERAPY. IRANIAN JOURNAL OF IMMUNOLOGY (IJI), 5(1), 1-24. SID. https://sid.ir/paper/296800/en

Vancouver: Copy

NOURI ARIA K.T.. RECENT PROGRESS IN ALLERGEN IMMUNOTHERAPY. IRANIAN JOURNAL OF IMMUNOLOGY (IJI)[Internet]. 2008;5(1):1-24. Available from: https://sid.ir/paper/296800/en

IEEE: Copy

K.T. NOURI ARIA, “RECENT PROGRESS IN ALLERGEN IMMUNOTHERAPY,” IRANIAN JOURNAL OF IMMUNOLOGY (IJI), vol. 5, no. 1, pp. 1–24, 2008, [Online]. Available: https://sid.ir/paper/296800/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops